首页 > 最新文献

Pharmacology, Toxicology and Biomedical Reports最新文献

英文 中文
Pharmacy Technician Job Satisfaction with Communication and Relationships Factors in Saudi Arabia 沙特阿拉伯药学技术人员工作满意度与沟通和关系因素
Pub Date : 2019-08-17 DOI: 10.5530/PTB.2019.5.26
Y. Alomi, Faiz A Bahadig Rph, R. Alsubaie, B. Alghuraybi, Budoor Emad Aloumi
Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care, Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Faiz A. Bahadig Rph, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA. Reem Saad Alsubaie, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Bayan Ibrahim Alghuraybi, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Budoor Emad Aloumi, Pharmacist, Pharmaceutical Care Services, Ministry of National Guard – Health Affairs. KAMC Central Region, SAUDI ARABIA.
Yousef Ahmed Alomi*,沙特阿拉伯利雅得国家药学总局原总经理、国家临床药学与药学实践原局长、卫生部药品研发管理局原局长。Faiz A. Bahadig注册博士,沙特阿拉伯国民警卫队吉达市阿卜杜勒-阿齐兹国王医院药学护理部信息学药剂师。Reem Saad Alsubaie,沙特阿拉伯利雅得苏丹王子军事医疗城药房服务部。Bayan Ibrahim Alghuraybi,沙特阿拉伯利雅得苏丹王子军事医疗城药房服务。Budoor Emad Aloumi,药剂师,国民警卫队-卫生事务部药物保健服务。沙特阿拉伯KAMC中部地区。
{"title":"Pharmacy Technician Job Satisfaction with Communication and Relationships Factors in Saudi Arabia","authors":"Y. Alomi, Faiz A Bahadig Rph, R. Alsubaie, B. Alghuraybi, Budoor Emad Aloumi","doi":"10.5530/PTB.2019.5.26","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.26","url":null,"abstract":"Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care, Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Faiz A. Bahadig Rph, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA. Reem Saad Alsubaie, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Bayan Ibrahim Alghuraybi, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Budoor Emad Aloumi, Pharmacist, Pharmaceutical Care Services, Ministry of National Guard – Health Affairs. KAMC Central Region, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130902595","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Communication and Relationships Factors of Pharmacy Career Satisfaction in Saudi Arabia 沙特阿拉伯药学职业满意度的沟通与关系因素
Pub Date : 2019-08-17 DOI: 10.5530/PTB.2019.5.23
Y. Alomi, F. Bahadig, Saima Qaism, K. Shahzad, Budoor Emad Aloumi, B. Alghuraybi, R. Alsubaie
Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care, Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Faiz A. Bahadig, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA. Saima Qaism, Senior Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical City-Jeddah, Ministry of National Guard, SAUDI ARABIA. Khurram Shahzad, Senior Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical City-Jeddah, Ministry of National Guard, SAUDI ARABIA. Budoor Emad Aloumi, Pharmacist, Pharmaceutical Care Services, Ministry of National Guard – Health Affairs. KAMC Central Region, SAUDI ARABIA. Bayan Ibrahim Alghuraybi, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Reem Saad Alsubaie, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA.
Yousef Ahmed Alomi*,沙特阿拉伯利雅得国家药学总局原总经理、国家临床药学与药学实践原局长、卫生部药品研发管理局原局长。Faiz A. Bahadig,沙特阿拉伯国民警卫队吉达市阿卜杜勒-阿齐兹国王医院药学护理部信息学药剂师。Saima Qaism,高级药剂师,吉达国王阿卜杜勒-阿齐兹医疗城药学护理部,沙特阿拉伯国民警卫队。Khurram Shahzad,沙特阿拉伯国民警卫队吉达国王阿卜杜勒-阿齐兹医疗城药学护理部高级药剂师。Budoor Emad Aloumi,药剂师,国民警卫队-卫生事务部药物保健服务。沙特阿拉伯KAMC中部地区。Bayan Ibrahim Alghuraybi,沙特阿拉伯利雅得苏丹王子军事医疗城药房服务。Reem Saad Alsubaie,沙特阿拉伯利雅得苏丹王子军事医疗城药房服务部。
{"title":"Communication and Relationships Factors of Pharmacy Career Satisfaction in Saudi Arabia","authors":"Y. Alomi, F. Bahadig, Saima Qaism, K. Shahzad, Budoor Emad Aloumi, B. Alghuraybi, R. Alsubaie","doi":"10.5530/PTB.2019.5.23","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.23","url":null,"abstract":"Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care, Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Faiz A. Bahadig, Informatics Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical, City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA. Saima Qaism, Senior Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical City-Jeddah, Ministry of National Guard, SAUDI ARABIA. Khurram Shahzad, Senior Pharmacist, Pharmaceutical Care Department, King Abdul-Aziz Medical City-Jeddah, Ministry of National Guard, SAUDI ARABIA. Budoor Emad Aloumi, Pharmacist, Pharmaceutical Care Services, Ministry of National Guard – Health Affairs. KAMC Central Region, SAUDI ARABIA. Bayan Ibrahim Alghuraybi, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Reem Saad Alsubaie, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117277925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Antimicrobial Drug Consumption in Ambulatory Care Settings, Tabuk Region, Saudi Arabia 沙特阿拉伯Tabuk地区门诊护理机构的抗菌药物消费
Pub Date : 2019-08-17 DOI: 10.5530/PTB.2019.5.18
Abeer Hussin Almasoudi, Y. Alomi, G. Alghamdi
Abeer Hussin Almasoudi, Director, Administration of Research and Studies, Ministry of Health, Tabuk, SAUDI ARABIA. Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care, Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Ghormallah Abdullah Alghamdi, Consultant Family Medicine, General Manager of Health Affairs in Tabuk Region, Ministry of Health, Tabuk, SAUDI ARABIA.
Abeer Hussin Almasoudi,沙特阿拉伯塔布克卫生部研究管理处主任。Yousef Ahmed Alomi*,沙特阿拉伯利雅得国家药学总局原总经理、国家临床药学与药学实践原局长、卫生部药品研发管理局原局长。Ghormallah Abdullah Alghamdi,家庭医学顾问,沙特阿拉伯塔布克卫生部塔布克地区卫生事务总经理。
{"title":"Antimicrobial Drug Consumption in Ambulatory Care Settings, Tabuk Region, Saudi Arabia","authors":"Abeer Hussin Almasoudi, Y. Alomi, G. Alghamdi","doi":"10.5530/PTB.2019.5.18","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.18","url":null,"abstract":"Abeer Hussin Almasoudi, Director, Administration of Research and Studies, Ministry of Health, Tabuk, SAUDI ARABIA. Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care, Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Ghormallah Abdullah Alghamdi, Consultant Family Medicine, General Manager of Health Affairs in Tabuk Region, Ministry of Health, Tabuk, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129819649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Antimicrobial Drug Consumption in Emergency Services at North West (Tabuk) Region Hospitals, Saudi Arabia 沙特阿拉伯西北(塔布克)地区医院急诊服务中的抗菌药物消费
Pub Date : 2019-08-17 DOI: 10.5530/PTB.2019.5.20
Y. Alomi, Abeer Hussin Almasoudi, G. Alghamdi, N. Abboud
Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care, Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Abeer Hussin Almasoudi, Director, Administration of Research and Studies, Ministry of Health, Tabuk, SAUDI ARABIA. Ghormallah Abdullah Alghamdi, Consultant Family Medicine, General Manager of Health Affairs in Tabuk Region, Ministry of Health, Tabuk, SAUDI ARABIA. Nora Ali Abboud, Clinical Pharmacy Staff, Ministry of Health, Riyadh, SAUDI ARABIA.
Yousef Ahmed Alomi*,沙特阿拉伯利雅得国家药学总局原总经理、国家临床药学与药学实践原局长、卫生部药品研发管理局原局长。Abeer Hussin Almasoudi,沙特阿拉伯塔布克卫生部研究管理处主任。Ghormallah Abdullah Alghamdi,家庭医学顾问,沙特阿拉伯塔布克卫生部塔布克地区卫生事务总经理。诺拉·阿里·阿布德,沙特阿拉伯利雅得卫生部临床药学工作人员。
{"title":"Antimicrobial Drug Consumption in Emergency Services at North West (Tabuk) Region Hospitals, Saudi Arabia","authors":"Y. Alomi, Abeer Hussin Almasoudi, G. Alghamdi, N. Abboud","doi":"10.5530/PTB.2019.5.20","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.20","url":null,"abstract":"Yousef Ahmed Alomi* , The Former General Manager of General Administration of Pharmaceutical Care, Former Head, National Clinical Pharmacy and Pharmacy Practice, Former Head, Pharmacy R&D Administration, Ministry of Health, Riyadh, SAUDI ARABIA. Abeer Hussin Almasoudi, Director, Administration of Research and Studies, Ministry of Health, Tabuk, SAUDI ARABIA. Ghormallah Abdullah Alghamdi, Consultant Family Medicine, General Manager of Health Affairs in Tabuk Region, Ministry of Health, Tabuk, SAUDI ARABIA. Nora Ali Abboud, Clinical Pharmacy Staff, Ministry of Health, Riyadh, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"43 4-7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132971691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Intake of antibiotics and fasting during the holy month of Ramadan: A Literature Review 在斋月期间摄入抗生素和禁食:文献综述
Pub Date : 2019-08-01 DOI: 10.5530/PTB.2019.5.11
Y. Alomi, M. Altuwaijri, Mohsen Huraybie Alshammari, Nouf Hameed Al-Muallad
{"title":"Intake of antibiotics and fasting during the holy month of Ramadan: A Literature Review","authors":"Y. Alomi, M. Altuwaijri, Mohsen Huraybie Alshammari, Nouf Hameed Al-Muallad","doi":"10.5530/PTB.2019.5.11","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.11","url":null,"abstract":"","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123467758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pattern use of Non-steroidal Anti-inflammatory Drugs among Saudi Community: Patients' Perspective 非甾体抗炎药在沙特社区的模式使用:患者的观点
Pub Date : 2019-08-01 DOI: 10.5530/PTB.2019.5.15
Amani Abdullah Bahdailah
Phone no: +966 505235901 E-mail: abahdealah@yahoo.com ABSTRACT Objectives: In this study, we aimed to explore the utilization of public use of non-steroidal anti-inflammatory drugs (NSAIDs) among the participants from the major metropolitan areas in Saudi Arabia. Methodology: This is a cross-sectional study conducted over a period of 6 months. The study questionnaire was randomly distributed via digital media using Survey Monkey system to individuals in the Kingdom of Saudi Arabia. The questionnaire comprised 24 questions related to demographic data; age; education; socioeconomic status; weight; history of chronic disease; history of pain; frequency, type and dosage of NSAIDs; and indication for the use of NSAIDs. The survey web link was distributed via social media to a convenient sample of participants. Data were tabulated and analyzed by using SPSS version 13 software. Results: The survey questionnaire was distributed to 3000 patients and a total of 500 participants responded, making the response rate as 16.6%. Of them, the highest percentage of responders belonged to the age group of above 40 years (52.63%, n=263). Majority of the responders had a university degree (66.20%, n=329). Of all the responders, 54% (n=272) did not use painkillers daily, whereas 43.33% (n=216) took painkillers daily; 2.26% (n=11) of the responders did not remember. Around 87% (n=433) of the responders tool an average of 1–3 NSAIDs daily, 11.44% (n=57) took 4–7 NSAIDs daily and 1.49% (n=7) responders took 8–12 NSAIDs daily without a prescription. Furthermore, 0.50% (n=2) of the responders took more than 12 NSAIDs per day. Conclusion: The NSAIDs are highly utilized in the Kingdom of Saudi Arabia. Therefore, the number of awareness programs for the public about the side effects of shortand long-term use of NSAIDs is highly recommended in Saudi Arabia.
摘要目的:在本研究中,我们旨在探讨来自沙特阿拉伯主要大都市地区的参与者在公共场合使用非甾体类抗炎药(NSAIDs)的情况。方法:这是一项为期6个月的横断面研究。研究问卷通过数字媒体使用调查猴子系统随机分发给沙特阿拉伯王国的个人。问卷包括24个与人口统计数据有关的问题;年龄;教育;社会经济地位;重量;慢性病史;疼痛史;非甾体抗炎药的使用频率、种类和剂量;以及使用非甾体抗炎药的适应症调查的网络链接通过社交媒体分发给方便的参与者样本。采用SPSS 13软件对数据进行制表和分析。结果:向3000名患者发放调查问卷,共有500人回复,回复率为16.6%。其中,40岁以上的应答者比例最高(52.63%,n=263)。大多数应答者具有大学学历(66.20%,n=329)。在所有应答者中,54% (n=272)未每日使用止痛药,43.33% (n=216)每日使用止痛药;2.26% (n=11)的应答者不记得。约87% (n=433)的应答者平均每天服用1-3种非甾体抗炎药,11.44% (n=57)的应答者每天服用4-7种非甾体抗炎药,1.49% (n=7)的应答者每天服用8-12种非甾体抗炎药。此外,0.50% (n=2)的应答者每天服用12个以上的非甾体抗炎药。结论:非甾体抗炎药在沙特阿拉伯王国的使用率很高。因此,强烈建议在沙特阿拉伯为公众提供关于短期和长期使用非甾体抗炎药副作用的意识项目。
{"title":"Pattern use of Non-steroidal Anti-inflammatory Drugs among Saudi Community: Patients' Perspective","authors":"Amani Abdullah Bahdailah","doi":"10.5530/PTB.2019.5.15","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.15","url":null,"abstract":"Phone no: +966 505235901 E-mail: abahdealah@yahoo.com ABSTRACT Objectives: In this study, we aimed to explore the utilization of public use of non-steroidal anti-inflammatory drugs (NSAIDs) among the participants from the major metropolitan areas in Saudi Arabia. Methodology: This is a cross-sectional study conducted over a period of 6 months. The study questionnaire was randomly distributed via digital media using Survey Monkey system to individuals in the Kingdom of Saudi Arabia. The questionnaire comprised 24 questions related to demographic data; age; education; socioeconomic status; weight; history of chronic disease; history of pain; frequency, type and dosage of NSAIDs; and indication for the use of NSAIDs. The survey web link was distributed via social media to a convenient sample of participants. Data were tabulated and analyzed by using SPSS version 13 software. Results: The survey questionnaire was distributed to 3000 patients and a total of 500 participants responded, making the response rate as 16.6%. Of them, the highest percentage of responders belonged to the age group of above 40 years (52.63%, n=263). Majority of the responders had a university degree (66.20%, n=329). Of all the responders, 54% (n=272) did not use painkillers daily, whereas 43.33% (n=216) took painkillers daily; 2.26% (n=11) of the responders did not remember. Around 87% (n=433) of the responders tool an average of 1–3 NSAIDs daily, 11.44% (n=57) took 4–7 NSAIDs daily and 1.49% (n=7) responders took 8–12 NSAIDs daily without a prescription. Furthermore, 0.50% (n=2) of the responders took more than 12 NSAIDs per day. Conclusion: The NSAIDs are highly utilized in the Kingdom of Saudi Arabia. Therefore, the number of awareness programs for the public about the side effects of shortand long-term use of NSAIDs is highly recommended in Saudi Arabia.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"173 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125993722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Basic Knowledge of Non-steroidal Anti-inflammatory Drugs among Saudi Community 沙特民众对非甾体类抗炎药的基本了解
Pub Date : 2019-08-01 DOI: 10.5530/PTB.2019.5.17
Amani Abdullah Bahdailah
Phone no: +966 505235901 E-mail: abahdealah@yahoo.com ABSTRACT Objectives: The use of non-steroidal anti-inflammatory drugs (NSAIDs) is a rising problem in the modern medical world. NSAIDs are easily available over the counter and accessible to the public. As such, we have seen a need to assess the knowledge and perception of public use of NSAIDs. In this study, we aimed to explore the knowledge of public use of NSAIDs among the participants from major metropolitan areas in the Kingdom of Saudi Arabia. Methodology: This is a cross-sectional study conducted for a period of 6 months using a questionnaire, which was developed to evaluate the use of NSAIDs in several major metropolitan areas among the Kingdom of Saudi Arabia. This questionnaire was randomly distributed digitally using the Survey Monkey system to individuals in the Kingdom of Saudi Arabia via social networking sites. The survey collected demographic data, age, education, socioeconomic status. The patient knowledge about the administration of NSAIDs status with meals, side effects, expiry date, resource information and related knowledge issues. The data were tabulated and analyzed by using SPSS version 13. Results: In this study, a total of 3000 patients received the questionnaire and of them, 500 responded, which means the response rate was 16.6%. The highest percentage of responders were in the age group of 40 years and above (52.63% n=263). Majority of the responders were those who had a university degree (66.20% (n=329)). According to our results, 63.31% (n=316) of the participants they knew how to take NSAIDs, i.e. with or without food is essential. Approximately 45% (n=224) of the participants knew about the possible side effects of NSAIDs. Half of the study population thought that expiry date is the time by which drugs become ineffective, whereas 33.81% (n=169) of the participants thought that drugs become toxic after this time. Around 61.87% (n=309) of the participants obtained information about NSAIDs from the package insert, whereas 32.45% (n=162) of the participants obtained information from the internet. Conclusion: The primary knowledge regarding NSAIDs is inadequate in the Kingdom of Saudi Arabia. Patient education about NSAIDs is highly recommended at healthcare institutions to prevent drug-related mistake, reduce economic burden on the healthcare system in Saudi Arabia.
摘要目的:非甾体抗炎药(NSAIDs)的使用是现代医学界一个日益突出的问题。非甾体抗炎药很容易在柜台上买到,公众也可以买到。因此,我们认为有必要评估公众使用非甾体抗炎药的知识和认知。在这项研究中,我们旨在探讨来自沙特阿拉伯王国主要大都市地区的参与者对公共使用非甾体抗炎药的了解。方法:这是一项为期6个月的横断面研究,采用问卷调查的方式,旨在评估沙特阿拉伯王国几个主要大都市地区非甾体抗炎药的使用情况。本问卷通过社交网站使用Survey Monkey系统随机分发给沙特阿拉伯王国的个人。这项调查收集了人口统计数据、年龄、教育程度、社会经济地位。患者对非甾体抗炎药的使用情况、膳食、副作用、有效期、资源信息和相关知识问题的了解。采用SPSS 13对数据进行制表和分析。结果:本次研究共有3000名患者收到问卷,其中500名患者回复,回复率为16.6%。40岁及以上年龄组应答者比例最高(52.63% n=263)。大多数应答者拥有大学学位(66.20% (n=329))。根据我们的结果,63.31% (n=316)的参与者知道如何服用非甾体抗炎药,即有或没有食物是必不可少的。大约45% (n=224)的参与者知道非甾体抗炎药可能的副作用。一半的研究人群认为有效期是药物失效的时间,而33.81% (n=169)的参与者认为过期后药物会产生毒性。约61.87% (n=309)的参与者通过药品说明书获取NSAIDs相关信息,32.45% (n=162)的参与者通过互联网获取相关信息。结论:沙特阿拉伯王国对非甾体抗炎药的初步认识不足。强烈建议医疗机构对患者进行非甾体抗炎药的教育,以防止与药物有关的错误,减轻沙特阿拉伯医疗保健系统的经济负担。
{"title":"Basic Knowledge of Non-steroidal Anti-inflammatory Drugs among Saudi Community","authors":"Amani Abdullah Bahdailah","doi":"10.5530/PTB.2019.5.17","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.17","url":null,"abstract":"Phone no: +966 505235901 E-mail: abahdealah@yahoo.com ABSTRACT Objectives: The use of non-steroidal anti-inflammatory drugs (NSAIDs) is a rising problem in the modern medical world. NSAIDs are easily available over the counter and accessible to the public. As such, we have seen a need to assess the knowledge and perception of public use of NSAIDs. In this study, we aimed to explore the knowledge of public use of NSAIDs among the participants from major metropolitan areas in the Kingdom of Saudi Arabia. Methodology: This is a cross-sectional study conducted for a period of 6 months using a questionnaire, which was developed to evaluate the use of NSAIDs in several major metropolitan areas among the Kingdom of Saudi Arabia. This questionnaire was randomly distributed digitally using the Survey Monkey system to individuals in the Kingdom of Saudi Arabia via social networking sites. The survey collected demographic data, age, education, socioeconomic status. The patient knowledge about the administration of NSAIDs status with meals, side effects, expiry date, resource information and related knowledge issues. The data were tabulated and analyzed by using SPSS version 13. Results: In this study, a total of 3000 patients received the questionnaire and of them, 500 responded, which means the response rate was 16.6%. The highest percentage of responders were in the age group of 40 years and above (52.63% n=263). Majority of the responders were those who had a university degree (66.20% (n=329)). According to our results, 63.31% (n=316) of the participants they knew how to take NSAIDs, i.e. with or without food is essential. Approximately 45% (n=224) of the participants knew about the possible side effects of NSAIDs. Half of the study population thought that expiry date is the time by which drugs become ineffective, whereas 33.81% (n=169) of the participants thought that drugs become toxic after this time. Around 61.87% (n=309) of the participants obtained information about NSAIDs from the package insert, whereas 32.45% (n=162) of the participants obtained information from the internet. Conclusion: The primary knowledge regarding NSAIDs is inadequate in the Kingdom of Saudi Arabia. Patient education about NSAIDs is highly recommended at healthcare institutions to prevent drug-related mistake, reduce economic burden on the healthcare system in Saudi Arabia.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115540401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Factors (gender, age, social status, and income) affecting the satisfaction of pharmacy career in Saudi Arabia 影响沙特阿拉伯药学职业满意度的因素(性别、年龄、社会地位和收入)
Pub Date : 2019-08-01 DOI: 10.5530/PTB.2019.5.16
Y. Alomi, Faiz A Bahadig Rph, R. Alsubaie, B. Alghuraybi, Budoor Emad Aloumi
Yousef Ahmed Alomi*, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Faiz Abdullah Bahadig RPH, Department of Pharmaceutical Care, King Abdulaziz Medical City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA. Reem Saad Alsubaie, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Bayan Ibrahim Alghuraybi, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Budoor Emad Aloumi, Pharmaceutical Care Services, Ministry of National Guard Health Affairs. KAMC – Central Region, SAUDI ARABIA.
Yousef Ahmed Alomi*,沙特阿拉伯利雅得卫生部药品保健总局。Faiz Abdullah Bahadig RPH,沙特阿拉伯国民警卫队吉达国王阿卜杜勒阿齐兹医疗城药物保健部。Reem Saad Alsubaie,沙特阿拉伯利雅得苏丹王子军事医疗城药房服务部。Bayan Ibrahim Alghuraybi,沙特阿拉伯利雅得苏丹王子军事医疗城药房服务。Budoor Emad Aloumi,国民警卫队卫生事务部药品保健服务部。KAMC -中部地区,沙特阿拉伯。
{"title":"Factors (gender, age, social status, and income) affecting the satisfaction of pharmacy career in Saudi Arabia","authors":"Y. Alomi, Faiz A Bahadig Rph, R. Alsubaie, B. Alghuraybi, Budoor Emad Aloumi","doi":"10.5530/PTB.2019.5.16","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.16","url":null,"abstract":"Yousef Ahmed Alomi*, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, SAUDI ARABIA. Faiz Abdullah Bahadig RPH, Department of Pharmaceutical Care, King Abdulaziz Medical City-WR-Jeddah, Ministry of National Guard, SAUDI ARABIA. Reem Saad Alsubaie, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Bayan Ibrahim Alghuraybi, Pharmacy Services, Prince Sultan Military Medical City, Riyadh, SAUDI ARABIA. Budoor Emad Aloumi, Pharmaceutical Care Services, Ministry of National Guard Health Affairs. KAMC – Central Region, SAUDI ARABIA.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"8 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128619650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Drug therapy for chronic diseases during the holy month of Ramadan: a literature review 斋月期间慢性病的药物治疗:文献综述
Pub Date : 2019-08-01 DOI: 10.5530/PTB.2019.5.13
Y. Alomi, Ban Abdullah Aldosary, N. F. Aldawas
Objectives: In this study, we aimed to review the drug therapy for chronic diseases during the holy month of Ramadan. Methods: In this study, we conducted an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. Medication list related to the gastrointestinal tract diseases, asthma and rheumatoid arthritis and the switch from regular days to Ramadan days revealed comparative safety, efficacy studies, cost of type of medication for each disease studies and national or international evidence based guidelines of switching short half-life to long half-life. All parenteral dosage form of medication were excluded from the analysis. All medications should be listed in the MOH drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that 27 studies investigated medications related to the gastrointestinal diseases and Ramadan and 15 studies were about medicines for asthma and rheumatoid arthritis and Ramadan. Of those 42 studies of Ramadan and chronic diseases, only 5 studies were found to be appropriate for further evaluation. The suggested draft of list of medications of chronic diseases from regular days to the Ramadan days is explored in the review. Conclusion: The guidelines medications of chronic disease (Asthma, RA, GIT disease) intake during the holy month of Ramadan is not found. The studies of drug schedules in Ramadan does not exist. The investigations about medications therapy of chronic disease are highly recommended in Muslim countries.
目的:在本研究中,我们旨在回顾斋月期间慢性疾病的药物治疗。方法:在本研究中,我们通过沙特数字图书馆搜索引擎对50个数据库进行了广泛的搜索。我们纳入了2017年5月以英语发表的荟萃分析、随机对照研究和观察性研究。搜索词包括斋月、禁食、药物、治疗、疾病类型和基于治疗类别的药物。与胃肠道疾病、哮喘和类风湿关节炎相关的药物清单以及从常规日到斋月日的转换揭示了比较安全性、有效性研究、每种疾病研究的药物类型成本以及将短半衰期转换为长半衰期的国家或国际循证指南。所有的肠外用药剂型均被排除在分析之外。所有药物都应列在卫生部药物处方中。结果:在广泛搜索特定术语后,共获得710项研究。其中104项研究为重复研究,606项研究纳入进一步评价。评价结果显示,27项研究调查了与胃肠道疾病和斋月有关的药物,15项研究调查了哮喘和类风湿关节炎与斋月有关的药物。在这42项关于斋月和慢性病的研究中,只有5项研究被认为适合作进一步评价。在审查中探讨了从正常日到斋月日的慢性病药物清单建议草案。结论:斋月期间未发现慢性疾病(哮喘、类风湿关节炎、胃肠道疾病)的指南用药。关于斋月期间用药时间表的研究并不存在。穆斯林国家强烈建议对慢性病的药物治疗进行调查。
{"title":"Drug therapy for chronic diseases during the holy month of Ramadan: a literature review","authors":"Y. Alomi, Ban Abdullah Aldosary, N. F. Aldawas","doi":"10.5530/PTB.2019.5.13","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.13","url":null,"abstract":"Objectives: In this study, we aimed to review the drug therapy for chronic diseases during the holy month of Ramadan. Methods: In this study, we conducted an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease, and medication based on therapeutic class. Medication list related to the gastrointestinal tract diseases, asthma and rheumatoid arthritis and the switch from regular days to Ramadan days revealed comparative safety, efficacy studies, cost of type of medication for each disease studies and national or international evidence based guidelines of switching short half-life to long half-life. All parenteral dosage form of medication were excluded from the analysis. All medications should be listed in the MOH drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that 27 studies investigated medications related to the gastrointestinal diseases and Ramadan and 15 studies were about medicines for asthma and rheumatoid arthritis and Ramadan. Of those 42 studies of Ramadan and chronic diseases, only 5 studies were found to be appropriate for further evaluation. The suggested draft of list of medications of chronic diseases from regular days to the Ramadan days is explored in the review. Conclusion: The guidelines medications of chronic disease (Asthma, RA, GIT disease) intake during the holy month of Ramadan is not found. The studies of drug schedules in Ramadan does not exist. The investigations about medications therapy of chronic disease are highly recommended in Muslim countries.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127074923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular medication therapy during the holy month of Ramadan: a literature review 斋月期间心血管药物治疗:文献综述
Pub Date : 2019-08-01 DOI: 10.5530/PTB.2019.5.12
Y. Alomi, A. Al-Najjar
Phone no: +966504417712 E-mail: yalomi@gmail.com ABSTRACT Objectives: To review cardiovascular medication therapy during the Holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease and medication based on therapeutic class. The list of cardiovascular medications and switch from regular days to Ramadan days based on literature revealed that’s included comparative safety studies, efficacy and cost of type of medication for each disease studies and national or international evidence-based guidelines of switching short half-life to long half-life. All parenteral dosage form of medication were excluded from this study. All medications should be listed in the Ministry of Health drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that there were 30 studies published on cardiovascular medications and Ramadan. Seven studies were further evaluated. The authors recommend to have a list of cardiovascular medications that can be switched from regular days to Ramadan days. Conclusion: There were very studies about cardiovascular medications use during the holy month of Ramadan. Suggested usage of the frequency administration single or twice daily is required during fasting. Future investigations of cardiovascular medication intake during Ramadan is highly recommended in Muslim countries.
摘要目的:回顾斋月期间心血管药物治疗情况。方法:在本研究中,我们通过沙特数字图书馆搜索引擎对50个数据库进行了广泛的搜索。我们纳入了2017年5月以英语发表的荟萃分析、随机对照研究和观察性研究。搜索词包括斋月、禁食、药物、治疗、疾病类型和基于治疗类别的药物。根据文献显示,心血管药物清单和从常规日到斋月日的转换包括比较安全性研究,每种疾病研究的药物类型的功效和成本,以及国家或国际循证指南,将短半衰期转换为长半衰期。本研究排除了所有肠外用药剂型。所有药物均应列入卫生部药品处方表。结果:在广泛搜索特定术语后,共获得710项研究。其中104项研究为重复研究,606项研究纳入进一步评价。评估显示,有30项关于心血管药物和斋月的研究发表。对7项研究进行了进一步评价。作者建议有一份心血管药物清单,可以从正常的日子切换到斋月的日子。结论:关于斋月期间心血管药物使用的研究非常多。建议在禁食期间每天服用一次或两次。强烈建议穆斯林国家对斋月期间心血管药物摄入情况进行进一步调查。
{"title":"Cardiovascular medication therapy during the holy month of Ramadan: a literature review","authors":"Y. Alomi, A. Al-Najjar","doi":"10.5530/PTB.2019.5.12","DOIUrl":"https://doi.org/10.5530/PTB.2019.5.12","url":null,"abstract":"Phone no: +966504417712 E-mail: yalomi@gmail.com ABSTRACT Objectives: To review cardiovascular medication therapy during the Holy month of Ramadan. Methods: In this study, we performed an extensive search of 50 databases through the Saudi Digital Library search engine. We included meta-analysis, randomized controlled studies and observational studies published in English language in May 2017. The search terms included Ramadan, fasting, medication, therapy, type of disease and medication based on therapeutic class. The list of cardiovascular medications and switch from regular days to Ramadan days based on literature revealed that’s included comparative safety studies, efficacy and cost of type of medication for each disease studies and national or international evidence-based guidelines of switching short half-life to long half-life. All parenteral dosage form of medication were excluded from this study. All medications should be listed in the Ministry of Health drug formulary. Results: A total of 710 studies were obtained after an extensive search with specific terms. Of those, 104 studies were duplicate studies and 606 studies were included for further evaluation. The evaluation revealed that there were 30 studies published on cardiovascular medications and Ramadan. Seven studies were further evaluated. The authors recommend to have a list of cardiovascular medications that can be switched from regular days to Ramadan days. Conclusion: There were very studies about cardiovascular medications use during the holy month of Ramadan. Suggested usage of the frequency administration single or twice daily is required during fasting. Future investigations of cardiovascular medication intake during Ramadan is highly recommended in Muslim countries.","PeriodicalId":416050,"journal":{"name":"Pharmacology, Toxicology and Biomedical Reports","volume":"55 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131815502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pharmacology, Toxicology and Biomedical Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1